Oncology Ventures — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

Triomicstriomics.com in 𝕏Series B · Dec 2022 · $22M

Triomics builds AI systems for oncology teams that read full patient records and produce structured, auditable outputs for trial matching, visit preparation, and data curation.

AI & Machine LearningHealthtechMedical DevicesNew York City, US

Sarim Khan(Founder)inHrituraj Singh(Founder)inDevtosh Kumar Khare(Director)Aniket Jaiswal(Operations)Sebastien Rhodes(Director, Strategy and Operations)Daniel Novinson(Medical Director)

PartnerBen Freeberg· solo GP

Co-investorsBattery Ventures Y Combinator General Catalyst Jude Gomila Lightspeed India Partners Lightspeed Venture Partners +2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.